tbuckley/cabot-search huggingface dataset:
Die Hypertoniekrankheiten.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Current Concepts in Radiology
Authors: Joseph E. Whitley
Journal: JAMA (1973)

The avowed purpose of the book is to compile selected recent developments, scattered in the medical literature, that are important and applicable to radiologic practice. The preface states that the book is planned as the first of a series. There are several serial publications that are similar in concept with hard or soft backs; ie,<i>Current Problems in Radiology, Progress in Pediatric Radiology, Seminars in Roentgenology,</i>and<i>Radiologic Clinics of North America</i>. This initial volume is almost exclusively oriented toward diagnostic roentgenology. Thirteen topics were selected and appear in individual "chapters": three pertaining to pulmonary roentgenology, two to cardiology, and the others more or less isolated. The overall quality of the individual works is good to excellent with the chapters on pulmonary mechanics by E. N. C. Milne, pulmonary patterns by P. J. Friedman, and contrast agents by H. W. Fisher being outstanding. In short, this book compares favorably with
Evaluation of two antineoplastic agents, PIPOBROMAN (vercyte) and thioguanine
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BUCHAREST
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
1059P NEMIO: A randomized phase I-II trial evaluating efficacy and safety of dose dense MVAC (ddMVAC) + durvalumab +/- tremelimumab as neoadjuvant treatment in patients with bladder muscle-invasive urothelial carcinoma
Authors: C. Thibault, R.T. Elaidi, D. Pouessel, A. Fléchon, D. Borchiellini, P. Barthélémy, O. Huillard, M. Rouabah, E. Braychenko, I. Helali, F. Audenet, S. Oudard
Journal: Annals of Oncology (2020)
LONDON LETTER.
Authors: None G. O. M.
Journal: JAMA (1884)

London, Sept. 1884. The fixtures for the opening of the winter session at the medical schools of the metropolis have, with one exception, been made. The session 1884-85 of the London Hospital will commence on Wednesday, Oct. 18, when the prizes for the past session, and the nursing probationers prizes will be distributed at 8 P. M. by the Lord Mayor. The medical department of King's College will meet on the 1st of October at 4 P. M., when the prizes will be distributed, and an address given by the Rev. H. Wace, principal of King's College. The session both at St. Bartholomew's and Guy's hospitals will commence on the first of October, but for neither has an opening address been announced. At St. Thomas' Hospital Medical School the session will be opened on Wednesday, Oct. 1, when an introductory address will be delivered by Sir Risdon Bennett at 3
The Use of Autologous Blood-Reply
Journal: JAMA (1990)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Obituary: Sir GORDON GORDON-TAYLOR, K.B.E., C.B. M.D., Hon.LL.D., Hon.Sc.D., M.S., F.R.C.S., Hon.F.R.C.S.Ed., Hon.F.R.C.S.I., Hon.F.A.C.S., Hon.F.R.C.S.(Canada)
Journal: BMJ (1960)
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
Authors: David H. Chang, Keren Osman, John Connolly, Anjli Kukreja, Joseph Krasovsky, Maggi Pack, Aisha Hutchinson, Matthew Geller, Nancy Liu, Rebecca Annable, Jennifer Shay, Kelly Kirchhoff, Nobusuke Nishi, Yoshitaka Ando, Kunihiko Hayashi, Hani Hassoun, Ralph M. Steinman, Madhav V. Dhodapkar
Journal: The Journal of Experimental Medicine (2007)
The occupational and environmental health history
Authors: R. H. Goldman
Journal: JAMA (1981)

Occupational and environmental diseases frequently masquerade as routine medical disorders. Yet environmental factors rarely enter into the clinician's differential diagnosis. This article provides a sequence of steps that can be used by the practicing physician for detecting occupational diseases: Step 1: Routine screening questions for all patients (List of job titles? Exposure to fumes, dusts, chemicals, loud noise, or radiation? Temporal relationship of the chief complaint to activities at work or at home?). Step 2: Consideration of sources of exposure (workplace or home surroundings). Step 3: Identification and handling of the hazardous agent. Step 4: Follow-up, consultation, and resolution of the problem. Equipped with this approach, the clinician can play an important role in the detection and prevention of occupational- and environmental-related diseases. (<i>JAMA</i>1981;246:2831-2836)
Interpretation of Cellular Changes Preceding Invasive Uterine Cervix Carcinoma
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The allocation and rationing of high-cost services
Authors: John T. Ashley
Journal: JAMA (1986)

<h3>To the Editor.—</h3> The editorial by Knaus<sup>1</sup>entitled "Rationing, Justice, and the American Physician" in the March 7 issue of<i>JAMA</i>reached an appropriate conclusion that physicians should be involved in both allocation and rationing decisions in hospitals and in our health care system. I believe it is particularly important that physicians be involved in the allocation decisions primarily because physicians will have to make the crucial rationing decisions. From my experience, directly and in working with medical directors of many intensive care units, I do not believe that rationing decisions are "painless," as suggested by Dr Knaus. Dr Knaus suggested that rationing at Harborview Hospital was "ineffective at reducing costs." Although I was not at Harborview, I believe that anytime effective rationing occurs, institutions avoid further allocation of resources. I believe that rationing does reduce costs by reducing the amount of care that would be potentially provided. Rationing
The Italian National cardiological database: Integration of internet, smart cards and remote databases for a standardized hospital cardiological ?e-Record? and application environment Domenico Cianflone, Marco Tubaro, Pierfranco Ravizza, Fabio Fonda, Andrea Marchesini, Giancarlo Carini. on behalf of the G8Cardio-ANMCO Project, Rome, Italy
Journal: Journal of the American College of Cardiology (2001)
Organization Section
Authors: Kellie Antinori, Jean-Raymond Attali, France Bondy, Linda Baker, Wayne Baric, Ml Barkett, Joan Barrett, Sarah Batchelor, Ira Baum, Sandra Bedenarlzyk, Michael Beilan, Anna Bertorelli, Cindy Bochenski, Karin Bornfeldt, Marie Briasco, Douglas Bruce, J Brun, France Bucala, New York, Robert Burrows, Alessandro Cama, Mary Campbell, Badrieh Caraway, Madonna Carlson, San Diego, Janet Chiles, Ruei-Chen Chin, Palo Alto, Frank Chinsci, Hsu-Fang Chow, Palos Verdes, Min-Young Chung, Jane Cochrane, Kelly Cochrane, Walla Walla, Peggy Wa, Ok Coe, Mark Collins, Michele Colwell, Fort Corlette, Joseph Bragg, Ann Cornicelli, Marina Arbor, Martha Elisa Costa, Silvina Couce, Los Cox, Derek Angeles, Canada Davis, Rock Hill, William Dever, West Haven, Diana Durnam, Charise Ellsworth, Susan Elsen, Joseph Torrance, Keith Evans, San Everett, K Diego, Ta-Yun Falholt, Jane Fang, Los Farmer, Gafner Angeles, Emma Felix, Hato Fernandez, Waldo Rey, Pamela Flanders, Timothy Flannery, Blue Jay, Sharon Fogliano, Jeni Foran, Timothy Ford, Shirley Frost, Diana Gallagher, T Dallas, Eye Galusha, John Associates, Anne Garner, West Geller, Weryha Orange, France Gerasimidi, St Louis, Samuel Goldring, Steven Goodman, Mark Gorman, James Graham, Margaret Greco, Nancy Green, Diane Greene, Stewart Harris, Sioux Lookout, Christine Harrison, El Cajon, L Hedgren, Annamarie Heil, Joann Hendelman, Sheldon Hersh, Jane Hinckley, Martha Holland, Margaret Hubley, Yasunori Iwashima, Eric Johnson, Mildred Judd, Marian Kaczynski, Hassan Kanj, Tamara Kile, Penn Valley, Candace King, Annette Kirchgessner, Robyn Klenk, Nancy Kline, Suzette Knapp, Eugene Kovalik, Elaine Kubiak, Kathy Kunze, Virginia Beach, Stephen Kushner, Patricia Lagator, Patricia Baltimore, Diana Lange, Beverly Larocque, San Lauderdale, Ann Antonio, Dan Lefurgey, Leslie Lender, Mike Lescale-Matys, Joanne Levison, Houston Lichten, Jim Lieblong, Bryan Lipinski, Franklin David, Daniel Lockhart, Marvel Logan, Nelson Madrilejo, Robert Mahmarian, Kevin Maki, Downers Grove, Alan Martin, Luis Obispo, Joe Martin, Mary Martin, Carole Mason, Tatsuo Matsuyama, Minoo Osaka, Amy Japan, Timothy Mcauley, Mark Mcauliffe, Maura Mcclanahan, Thomas Cleveland, J Mcdonald, La Jolla, Mark Michael, Maggi Michels, Filomena Migdal, Alan Miller, Santa Monica, Margaret Miller, William Mitchell, John Monahan, Jim Moyer, Daniel Nelson, Gary Nelson, Luther Ness, Robert Wa, Nicholas Nyre, David Greece, Sylvie Picard, Patricia Podolin, Dennis Poffenroth
Journal: Diabetes Care (1991)
The clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.
Authors: Serdal Korkmaz, Mehmet Sinan Dal, Ilhami Berber, Deniz Goren Sahin, Mehmet Hilmi Dogu, Orhan Ayyildiz, Ilknur Nizam, Murat Albayrak, Ramazan Esen, Sinem Namdaroglu, Mehmet Sencan, Olga Meltem Akay, Sibel Kabukcu Hacioglu, Rahsan Yildirim, Ali Eser, Anil Tombak, Cigdem Pala, Osman Ilhan
Journal: Journal of Clinical Oncology (2014)

7108 Background: We aimed to investigate if older age leads to limitations in starting dose of imatinib in daily practice of chronic myeloid leukemia (CML) and the compliance with tyrosine kinase inhibitors (TKIs) therapy in elderly patients. Methods: To analyze the clinical characteristics and therapeutic outcomes of elderly patients with CML aged >65 years, data were collected from 13 institutions in Turkey, retrospectively. Results: A total of 69 cases were evaluated retrospectively. Of the patients, 42 (60.9%) were females. The median age was 71 years (range; 66-85). Ninety-six percent (66/69) of the patients were in chronic phase when diagnosed. Of the patients, 3 (4.3%) were in accelerated phase. The sokal risk at diagnosis was low in 3 patients, intermediate in 29 patients, and high in 37 patients. RT-PCR was the most used method to diagnose patients. Sixty-three (91.3%) patients were under imatinib tharapy as first line. The initial dose of imatinib was 400 mg/day in 59 (93.6%) patients, 100 mg/day in 2 (3.2%) patients, 300 mg/day in one (1.6%) patient, and 600 mg/day in one (1.6%) patient. Imatinib treatment induced 57 (90.5%) complete hematologic responses (CHR) at 3 months and 29 (46%) complete cytogenetic responses (CCyR) at 6 months, and 49 (77.7%) major molecular responses (MMR) at 12 months. Of the patients, 2 have discontinued imatinib for hematologic and/or non-hematologic toxicities; as a result of resistance in 7 patients, and loss of MMR in 5 patients, nilotinib and dasatinib were used in 14 patients as second-line therapy. Second-line TKIs induced 9 (64.3%) CHR at 3 months and 4 (28.6%) CCyR at 12 months, and 7 (50%) MMR at 18 months. Fifty-six (81.2%) of the patients are still alive and being followed up regularly. The median overall survival and progression free survival rates were 35 months (range; 1-95) and 17 months (range; 0.8-95), respectively. Conclusions: No need to reduce starting dose of imatinib and no upper age limit should be applied for the administration of TKIs to elderly patients with CML. Elderly patients should receive TKIs according to the same guidelines that apply to younger patients.
Special Announcement
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
BOOK REVIEWS
Authors: G. WILDING
Journal: JNCI Journal of the National Cancer Institute (1993)

BOOK REVIEWS Get access Cancer of the Prostate Sakti Das , E. David Crawford , eds. New York : Marcel Dekker , 1993 . 462 pp., illus. $135. ISBN 0-8247-8863-X . GEORGE WILDING, M.D. GEORGE WILDING, M.D. University of Wisconsin Comprehensive Cancer Center Department of Human Oncology K4/666 Clinical Science Center600 Highland Ave. Madison, WI 53792 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 85, Issue 23, 1 December 1993, Page 1958, https://doi.org/10.1093/jnci/85.23.1958 Published: 01 December 1993
Cost-Effective Treatment of Candida Esophagitis
Authors: Daniel S. Berman
Journal: Annals of Internal Medicine (1993)

Letters15 May 1993Cost-Effective Treatment of Candida EsophagitisDaniel S. Berman, MD and Barry D. Wenglin, MDDaniel S. Berman, MDSearch for more papers by this author and Barry D. Wenglin, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-118-10-199305150-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Laine and colleagues' demonstration [1] that fluconazole is more effective than ketoconazole in treating candida esophagitis in patients with AIDS does not alter our position that ketoconazole is the primary therapy.The investigators speak of endoscopic and clinical cure in the study patients. In treating human immunodeficiency virus (HIV)-infected patients over months and years, we have observed that it is the nature of candida pharyngitis and esophagitis to recur. We have also encountered the sequence of treatment failure with ketoconazole, followed by failure with fluconazoleeven high doses intravenously administeredand have had to use amphotericin B despite its ...REFERENCE1. Laine L, Dretler RH, Conteas CN, Tuazon C, Koster FM, Sattler F, et al. Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS: a randomized trial. Ann Intern Med. 1992; 117:655-60. Google Scholar Author, Article, and Disclosure InformationAuthors: Daniel S. Berman, MD; Barry D. Wenglin, MD PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 May 1993Volume 118, Issue 10Page: 824-825KeywordsAIDSAmphotericinCandidaEatingHIVPatientsPharyngitis ePublished: 15 August 2000 Issue Published: 15 May 1993 Copyright & PermissionsCopyright © 1993 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Renal transplantation
Authors: P. T. R. Thiruchelvam, M. Willicombe, N. Hakim, D. Taube, V. Papalois
Journal: BMJ (2011)

<h3>Abstract</h3> <b>Objective:</b> To evaluate the primary care communications initiative, which introduced NHSnet to primary care in Scotland. <b>Design:</b> Semi-structured telephone interviews, postal questionnaire. <b>Setting:</b> All 15 Scottish health boards, random sample of 1 in 3 of all Scottish general practices. <b>Participants:</b> Information management and technology managers of health boards, 355 practice managers in the general practices. <b>Main outcome measures:</b> Variations between health boards in styles of project management, means of connection to NHSnet, costs to general practices, and training provided. Practices9 levels of participation in initiative, initial use of NHSnet, and factors acting as incentives and disincentives to use of NHSnet. <b>Results:</b> 99% of Scottish general practices agreed to participate in initiative. Health boards varied significantly in project management styles (from minimal to total control), the nature of the networks they established (intranets or direct connections), costs to practices (from nothing to £125 per general practitioner per year), and training provided (from none to an extensive programme). In 56% of practices someone accessed NHSnet at least once a week. Practices varied considerably in amount of internet training received and staff groups targeted and in the intention to provide desktop access to NHSnet through a practice network. <b>Conclusion:</b> The initiative has successfully introduced a network that links Scottish general practices, health boards, and hospital trusts. However local variation in this “national” initiative may affect its use in primary care. Health authorities and general practices in England and Wales may wish to note these findings in order to avoid unhelpful variation.
Leukostasis Thrombi
Authors: LEO J. McCarthy
Journal: JAMA (1985)

<h3>To the Editor.—</h3> Elevated white blood cell counts especially those greater than 100,000/cu mm in leukemic patients are, at times, thought to be associated with "leukostasis thrombi" in the brain and lungs, causing obtundation and shortness of breath. This is often an indication for emergency leukocytopheresis to reduce the numbers of circulating white blood cells. Recently I performed leukocytopheresis repeatedly on a 53-year-old man with acute leukemia and an initial white blood cell count of 153,000/cu mm. Because of increasing shortness of breath, an open lung biopsy was done (Figure) and revealed a leukemic infiltrate, interstitial fibrosis, alveolar hemorrhage, and focal leukostasis without thrombi, as illustrated, and no pathogenic organisms. I believe that congestion of blood vessels is probably the usual pathology and not thrombi. I report this because no microscopic documentation of "leukostasis thrombi" in the brain or lung has, to my knowledge, been published.